Danielle Pasqualone

Danielle Pasqualone's Title

Danielle Pasqualone currently holds the prestigious position of General Counsel. In this role, she oversees all legal aspects of the organization, ensuring that the company's operations comply with relevant laws and regulations. Her extensive background in both molecular biology and law positions her uniquely to handle complex legal issues, particularly in the biotechnology sector.

Danielle Pasqualone's Education and Expertise

Danielle Pasqualone has a robust academic background that spans the fields of science and law. She earned her B.S. in Molecular Biology from Penn State University, followed by a Ph.D. in Molecular Biology from Cornell University. Her pursuit of legal expertise culminated in obtaining a J.D. from the University of California, Berkeley, School of Law. This unique combination of scientific and legal education equips her with a specialized skill set, enabling her to navigate the intricate landscape of intellectual property and biotechnology law.

Danielle Pasqualone's Background

Danielle Pasqualone's career is marked by a seamless integration of her scientific knowledge and legal acumen. Before transitioning fully into the legal field, she cultivated a deep understanding of molecular biology, which she now leverages to address the legal challenges in the biotech industry. Her role as General Counsel involves strategic decision-making and legal oversight, particularly in the realm of intellectual property. Joining Alector in 2019 as the Vice President of Intellectual Property, she has significantly contributed to the company's growth and innovation.

Danielle Pasqualone's Achievements

Since joining Alector in 2019, Danielle Pasqualone has been instrumental in shaping the company's global intellectual property strategy. Her expertise has been critical in securing and managing the company's IP portfolio, which is essential for maintaining a competitive edge in the biotech industry. She has also provided legal counsel on significant transactions, including collaborations with major entities like GlaxoSmithKline (GSK) and Adimab. These collaborations underscore her ability to facilitate high-stakes negotiations and her pivotal role in Alector's strategic alliances.